Supplementary Figure 2 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer

Supplementary Figure 2 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer

<p>Supplementary Figure 2. Proportion of samples with PD-L1 TPS ≥1%, ≥50%, ≥90% according to ATM mutation status (ATMMUT versus ATMWT).</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Biagio Ricciuti (14951247) (author)
Diğer Yazarlar:	Arielle Elkrief (15055750) (author), Joao Alessi (15561455) (author), Xinan Wang (15561458) (author), Yvonne Li (15561461) (author), Hersh Gupta (15561464) (author), Daniel M. Muldoon (15561467) (author), Arrien A. Bertram (14954848) (author), Federica Pecci (15561470) (author), Giuseppe Lamberti (15024714) (author), Alessandro Di Federico (15561473) (author), Adriana Barrichello (15561476) (author), Victor R. Vaz (15561479) (author), Malini Gandhi (15561482) (author), Elinton Lee (15561485) (author), Geoffrey I. Shapiro (14961801) (author), Hyesun Park (15561488) (author), Mizuki Nishino (15561491) (author), James Lindsay (15032271) (author), Kristen D. Felt (15561494) (author), Bijaya Sharma (15561497) (author), Andrew D. Cherniack (14959412) (author), Scott Rodig (15561500) (author), Daniel R. Gomez (15561503) (author), Narek Shaverdian (15561506) (author), Mehrdad Rakaee (15561509) (author), Chaitanya Bandlamudi (15047205) (author), Marc Ladanyi (15050661) (author), Pasi A. Janne (15561512) (author), Adam J. Schoenfeld (15022025) (author), Lynette M. Sholl (15032729) (author), Mark M. Awad (14961722) (author), Michael L. Cheng (15561515) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Molecular and Cellular Biology Cancer Detection and Diagnosis Therapeutic Research and Development Clinical Research and Trials Biomarkers Genetic biomarkers DNA Damage and Repair DNA repair Lung Cancer Precision Medicine Translational Research
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

Supplementary Figure 1. from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 10 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 11 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 12 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 13 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 14 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 15 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 16 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 17 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 18 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 19 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 20 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 21 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 22. from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 23. from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 24 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 25 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 26 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 27 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 28 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 29 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 3 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 4. from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 5 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 6 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 7 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 8 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 9 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 2 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 5 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Yazar:: Biagio Ricciuti (14951247)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data 1 from Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer
Yazar:: Kavya Ramkumar (16474203)
Baskı/Yayın Bilgisi: (2025)

Figure 1 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Yazar:: Gonzalo Rodriguez-Berriguete (15056057)
Baskı/Yayın Bilgisi: (2025)

Figure 2 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Yazar:: Gonzalo Rodriguez-Berriguete (15056057)
Baskı/Yayın Bilgisi: (2025)

Figure 3 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Yazar:: Gonzalo Rodriguez-Berriguete (15056057)
Baskı/Yayın Bilgisi: (2025)

Figure 4 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Yazar:: Gonzalo Rodriguez-Berriguete (15056057)
Baskı/Yayın Bilgisi: (2025)

Figure 5 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Yazar:: Gonzalo Rodriguez-Berriguete (15056057)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Yazar:: Gonzalo Rodriguez-Berriguete (15056057)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data from SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer
Yazar:: Min Wei (16918572)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data from SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer
Yazar:: Min Wei (16918572)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S2 from Clinical Relevance of <i>BRCA1</i> Promoter Methylation Testing in Patients with Ovarian Cancer
Yazar:: Félix Blanc-Durand (15049400)
Baskı/Yayın Bilgisi: (2025)

Cannot write session to /tmp/vufind_sessions/sess_lveqrqsqfh4jv6igufavbnu1oq